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Lead intoxication in humans is characterized by cognitive impairments, particularly in
the domain of memory, where evidence indicates that glutamatergic neurotransmission
may be impacted. Animal and cell culture studies have shown that lead decreases the
expression and activity of glutamine synthetase (GS) in astrocytes, yet the basis of this
effect is uncertain. To investigate the mechanism responsible, the present study exposed
primary astrocyte cultures to a range of concentrations of lead acetate (0–330 µM) for
up to 24 h. GS activity was significantly reduced in cells following 24 h incubation with
100 or 330 µM lead acetate. However, no reduction in GS activity was detected when
astrocytic lysates were co-incubated with lead acetate, suggesting that the mechanism
is not due to a direct interaction and involves intact cells. Since GS is highly sensitive
to oxidative stress, the capacity of lead to inhibit the clearance of hydrogen peroxide
(H2O2) was investigated. It was found that exposure to lead significantly diminished the
capacity of astrocytes to degrade H2O2, and that this was due to a reduction in the
effectiveness of the glutathione system, rather than to catalase. These results suggest
that the inhibition of GS activity in lead poisoning is a consequence of slowed H2O2
clearance, and supports the glutathione pathway as a primary therapeutic target.
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INTRODUCTION
A primary function of astrocytes is to recycle synaptically-released glutamate (Pow and Robinson,
1994). Unlike neurones, astrocytes express glutamine synthetase (GS; Norenberg and Martinez-
Hernandez, 1979; Ong et al., 1993; Robinson, 2000), which catalyzes the ATP-dependent
condensation of glutamate and ammonia to form glutamine (Rose et al., 2013), which is
subsequently released for uptake by neurones and deamidation to glutamate, in the glutamate-
glutamine cycle (Westergaard et al., 1995; Hertz et al., 1999). GS is particularly sensitive to
inactivation by iron-mediated oxidative stress (Fernandes et al., 2011), and consequently depleted
GS activity levels in tissue have often been used as an indicator of oxidative stress (Schor, 1988;
Robinson, 2000).
Studies have linked the toxicity of lead to elevated oxidative stress, with lead exposure
correlating with increased production of free radicals and a lowering of antioxidant reserves
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(Patrick, 2006; Rubino, 2015). In the brain, astrocytes contribute
to the defense against toxic metals, xenobiotics and oxidative
stress (Dringen et al., 2014). Hydrogen peroxide (H2O2), a
common source of oxidative stress, is generated during erobic
metabolism by the action of superoxide dismutases and several
oxidases. H2O2 is broken down in iron-catalyzed reactions
to form hydroxyl radicals, which react readily with proteins,
lipids and DNA, and are thus toxic to cells. To limit free
radical formation from H2O2, astrocytes utilize two main
antioxidant systems. The first of these, catalase, rapidly degrades
H2O2, even when the peroxide is applied acutely at high
concentrations (Dringen and Hamprecht, 1997). The rate of
H2O2 breakdown is significantly slowed by pre-incubating
astrocytes with the catalase inhibitor 3-amino-1,2,4-triazole
(3AT), and this is correlated with an increase in cell death
(Liddell et al., 2006).
The second antioxidant system is the glutathione pathway,
whereby H2O2 is reduced to water in a reaction catalyzed
by glutathione peroxidase (GPx). Glutathione (GSH) serves
as the electron donor, and is itself oxidized to glutathione
disulfide (GSSG). GSSG is reduced to GSH through the action
of glutathione reductase (GR; Dringen and Hamprecht, 1997;
Dringen et al., 2014). Astrocytes pre-incubated with buthionine
sulfoximine (BSO), a GSH synthesis inhibitor, show a marked
reduction in their rate of H2O2 clearance and an increase in cell
death (Liddell et al., 2006). Application of 3AT and BSO to inhibit
both antioxidant systems, futher retards H2O2 clearance rates
and exacerbates cell death (Liddell et al., 2006). The high cellular
GSH content of astrocytes, combined with their efficiency in
breaking down peroxides, protects astrocytes and neighboring
cells from oxidants and toxins (Dringen et al., 2014).
While several animal and cell culture studies have shown
that application of lead diminishes the expression and activity
of GS (Engle and Volpe, 1990; Sierra and Tiffany-Castiglioni,
1991), the basis of this effect is uncertain. The decrease in GS
activity may be due to lead binding to cysteine residues on GS,
thereby interfering with its catalytic activity (Tang et al., 1996;
Qian et al., 1999). Alternatively, GSmay be inactivated by reactive
oxygen species that result from a diminished effectiveness of
the GSH system. Lead binds to sulfhydryl groups, giving it an
affinity for GSH which then cannot act an antioxidant (Patrick,
2006). Lead can also bind to the catalytic site of GR, irreversibly
inhibiting the enzyme and preventing it from reducing GSSG to
GSH (Rubino, 2015). Impairment of the glutathione system will
decrease cellular antioxidative capacity and reduce protection
from oxidative stress (Scortegagna et al., 1998; Aykin-Burns et al.,
2003).
It is possible that lead binds to the active site of GS inhibiting
it directly, or the inhibition of lead may be a downstream
event, secondary to inactivation of the glutathione system. The
present study conducted experiments to discriminate between
these alternatives. Primary astrocyte cultures were exposed
to a range of concentrations of lead for up to 24 h. We
confirmed that GS activity is significantly lowered in cultures
following incubation with lead acetate. However we found
that this effect is not replicated when astrocyte lysates are
exposed to lead, suggesting that, when in the presence of
other cellular components, lead does not directly interfere
with the catalytic activity of GS. We also demonstrated that
lead limits the capacity of astrocytes to degrade H2O2, and
that this appears to be due to an impairment of the GSH
system.
MATERIALS AND METHODS
Materials
This study was carried out in accordance with the guidelines of
the National Health and Medical Research Council (NHMRC)
of Australia. The protocol was approved by Monash University’s
Psychology Animal Ethics Committee. Primary astrocyte cell
cultures were derived from newborn Wistar rat pups obtained
from Monash Animal Services. Constituents of growth media
were obtained from Gibco (Carlsbad, CA, USA): Dulbecco’s
modified Eagle medium (DMEM), fetal calf serum (FCS),
streptomycin sulfate and penicillin G. Triton X-100 was obtained
from Ajax Finechem (Seven Hills, Australia). Lead (II) acetate
trihydrate, BSO, 3AT, H2O2 and all other chemicals were
obtained from Sigma (Australia). Twenty four-well cell culture
dishes and 96-well microtiter plates were obtained from Greiner
Bio-One (Frickenhausen, Germany).
Cell Cultures
Primary astrocyte cultures were obtained from the brains of
newborn Wistar rat pups (<24 h old) as previously described
(Hamprecht and Löffler, 1985). Astrocytes were seeded at
approximately 3 × 105 cells/well in 24-well culture plates. Cells
were grown in humidified incubators (Heraeus Instruments) at
10% CO2. Growth medium was replaced every 6th or 7th day
until cultures were confluent, at which time they were used for
experimentation (14–21 days).
Cell Viability and Protein Content
The activity of lactate dehydrogenase (LDH) released by cells
into media by treated cells was measured to determine the
extent of cell death, as previously described (Dringen et al.,
1998). Hundred percent cell death values were derived from cells
lysed with Triton X-100. Cellular protein content per well was
determined via the Lowry method (Lowry et al., 1951).
GS Activity
GS activity was measured with a colorimetric assay (Fernandes
et al., 2011). To determine the effect of lead on GS activity,
cultures were incubated with 0, 33, 100 or 330 µM lead
acetate in DMEM for 2 or 24 h. Cells were washed with
ice-cold PBS and frozen at −20◦C for 30 min before
being warmed to 37◦C and lysed with 200 µl of 50 mM
imidazole/ HCl buffer (IHB), pH 7.2. After 5 min, 200 µl
of a reaction mix was added to the lysates (50 mM L-
glutamine, 2 mM manganese chloride, 25 mM sodium
arsenate, 0.16 mM ADP and 25 mM NH2OH∗HCl). Following
30 min incubation with the reaction mix, 800 µl of a
solution of 0.37 M ferric chloride (FeCl3), 0.67 M HCl and
0.2 M trichloroacetic acid was added to halt the reaction.
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Samples were transferred to microfuge tubes and centrifuged
for 5 min at 15000 g. Three hundred microliters of the
supernatant was transferred to a microtiter plate. Absorbances
were measured spectrophotometrically (Multiskan Ascent plate
reader, Thermo Labsystems) at 500 nm and the samples were
compared to standard solutions of the reaction product γ-
glutamylhydroxymate (0 and 1000 nmol), which had been
processed identically to the samples.
To examine the direct effect of lead on GS activity, a variation
of the method of (Santoro et al., 2001) was performed on lysed
astrocytes. Since 10 µM lead is reported to produce direct
and complete inhibition of GS (Sierra and Tiffany-Castiglioni,
1991), low concentrations of lead acetate were prepared to test
the concentration-dependency of lead inhibition: 0, 2.5, 5, 7.5
and 10 µM. To allow comparison with the incubations on live
cultures, lead concentrations of 33, 100 and 330 µM were also
analyzed. Untreated cell culture plates were washed, frozen and
brought to 37◦C as described above, then lysed with 100 µl of
100 mM IHB for 5 min. One Hundred microliters of lead acetate
in IHB was added to achieve the final concentrations listed above
and the lysate was incubated for a further 5 min. Two hundred
microliters of GS reaction mix was then applied for 30 min, with
the remaining steps as described for lead-incubated cell cultures.
For cell culture and lysed cell experiments, final GS activity
values were standardized against protein samples from cells or
lysates incubated with equivalent lead acetate concentrations,
thereby correcting for the loss of GS due to cell death. GS activity
was then expressed as a percentage of the control values (the
0 µM lead acetate treatments), to provide values for specific GS
activity.
H2O2 Clearance
In control cultures, the H2O2 clearance system was examined
independently of lead, including conditions that partially
inhibited H2O2 clearance for subsequent comparison to the
effects of lead. 3AT completely inhibits catalase activity within
2 h, whereas BSO requires 24 h to deplete GSH to 14% of
control levels (Dringen and Hamprecht, 1997). Therefore, the
BSO-containing treatments were pre-incubated for 18 h with
BSO in DMEM followed by a further 6 h with the addition of 3AT
and/or lead acetate, as appropriate. For comparability, conditions
not containing BSO received a 18 h pre-incubation in DMEM
only. Similarly, to study the effect of lead on H2O2 clearance,
lead-treated cultures were pre-incubated for 18 h with DMEM
only, then incubated with 0, 10, 33, 100 or 330 µM lead acetate
for 6 h, with or without the addition of 10 mM 3AT, prior to the
addition of H2O2.
For each replication of this experiment, the incubations were
carried out on three sets of cells. One set was used for the
H2O2 clearance assay, the second set for protein estimates to
standardize H2O2 clearance values, while the third set was used
to provide a 100% cell death control condition for the LDH assay
(Dringen et al., 1998).
The clearance of H2O2 was determined as previously
described (Dringen et al., 1998). After the incubations
described above, culture media was collected for the subsequent
measurement of released LDH. Cells were washed with
incubation buffer (IB; 20 mM HEPES, 145 mM NaCl, 0.8 mM
Na2HPO4, 5.4 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 and
5 mM glucose, pH 7.4) before adding a bolus of 500 µl IB
containing 100 µM H2O2. Ten microliters samples were taken
from each well after 2, 4, 6, 8, 10, 20 and 60 min and transferred
to microtiter wells containing 170 µl 25 mM sulfuric acid to
halt further degradation of H2O2. One hundred and eighty
microliters of a freshly made reaction mixture (100 mM sorbitol,
25 mM H2SO4, 0.25 mM (NH4)2Fe(SO4)2 and 100 µM xylenol
orange) was added to each well for 45 min. The resulting
color change was proportional to the concentration of H2O2
remaining in the sample. Absorbances were measured at 550 nm
and compared to standards of known H2O2 concentration.
To compare rates of H2O2 degradation across treatments and
cultures, results were standardized against protein values, and
half-times were calculated as previously described (Dringen et al.,
1998). Specific detoxification rate constants (D-values) were
calculated by taking the inverse of the product of protein content
and the half-time of H2O2 clearance. The D-values represent the
concentration of H2O2 that is cleared per minute, per mg of
protein.
Statistical Analysis
Each treatment condition and time point was performed in
triplicate and replicated on astrocyte cultures or lysates derived
from three independently prepared cultures. Data provided in
the results section represent mean ± SD. Values for GS activity
in cell cultures and cell lysates were analyzed using one-way
independent samples ANOVAs, with post hoc corrections, to
determine the effect of each lead concentration on GS activity at
each time point. Such analyses were also applied to data obtained
from the same cultures and processed through the LDH cell death
assay.
D-values calculated after H2O2 detoxification experiments
were analyzed with one-way independent samples ANOVAswith
treatment type (BSO, DMEM, BSO/3AT, 3AT, 10 µM lead/3AT,
33 µM lead/3AT, 100 µM lead/3AT, 330 µM lead/3AT, 10 µM
lead, 33 µM lead, 100 µM lead or 330 µM lead) being the
independent factor.
RESULTS
Effect of Lead Acetate on Specific GS
Activity and Cell Viability
In cultures treated with 0–330 µM lead acetate for 2 h, no
significant differences in specific GS activity were observed
between the control treatment and any of the lead concentrations
(F(3,32) = 0.396, p > 0.05). However, after 24 h, cells treated
with 100 or 330 µM lead acetate displayed a marked reduction
in specific GS activity (40–50%) when compared to control cells
(F(3,32) = 11.052, p> 0.05; Figure 1A).
Cell viability was examined after incubation with lead. After
2 h, 330 µM lead acetate caused a modest yet significant increase
in LDH release when compared to untreated cells and the other
lead acetate concentrations (F(16,19) = 6.415, p< 0.05; Figure 1B).
Frontiers in Integrative Neuroscience | www.frontiersin.org 3 December 2015 | Volume 9 | Article 61
Robinson et al. Lead Slows the Detoxification of H2O2
FIGURE 1 | Specific glutamine synthetase (GS) activity and cell viability
in rat astrocyte cultures after 2 or 24 h incubation with four
concentrations of lead acetate (0, 33, 100 and 330 µM). (A) Specific GS
activity expressed as a percentage of that in untreated cells. Each bar
represents mean ± SD of n = 9 samples. (B) Cell death as determined by
activity of Lactate dehydrogenase (LDH) released into the media. Each bar
represents means ± SD of n = 6 samples. ∗Significant differences between
lead-treated and untreated cells at their respective timepoint (p < 0.05).
By 24 h, 330 µM lead had caused a doubling of LDH release
(F(18,21) = 15.762, p< 0.05; Figure 1B), whereas values for 33 and
100 µM lead exposure did not differ significantly from controls.
The detectable activity of extracellular LDH showed a remarkable
linear correspondence as a function of lead concentration at both
time points examined. Thus at 2 h the correlation coefficient
was r = 0.957 and at 24 h the correlation coefficient was
r = 0.990.
Specific GS activity in astrocyte lysates was examined after
treatment with lead acetate. Compared to controls (0 µM lead),
no significant reduction of GS activity was found in lysates
for any lead acetate concentration (F(9,61) = 1.714, p > 0.05;
Figure 2).
Effect of Lead Acetate on H2O2 Clearance
by Astrocytes
The influence of lead on the capacity of astrocytes to degrade
H2O2 was examined. The peroxide clearance curves (Figure 3)
revealed that in all conditions investigated, except for BSO +
FIGURE 2 | Specific GS activity in astrocyte lysates incubated with
0–330 µM lead acetate for 35 min. Bars show means ± SD of n = 6
samples. No significant difference was found between control and treated
lysates.
3AT (Figure 3A), all of the H2O2 applied was cleared within
60 min. However, the rates of peroxide clearance differed
between conditions. While cultures treated with lead acetate
demonstrated a slightly slower rate of peroxide clearance in the
first 20 min compared with control cells (Figure 3B), the rates
of clearance were slowed substantially when the cells had been
exposed to both lead and the catalase inhibitor 3AT (Figure 3C),
indicating an additive effect.
Analysis of specific detoxification rate constants (D-values;
Figure 4), derived from the half-times of extracellular H2O2
degradation and the specific protein values, revealed a significant
effect of the treatments (F(11,87) = 148.180, p < 0.05).
Exposure of astrocytes to 10 or 100 µM lead acetate for 6 h
significantly slowed the rates of H2O2 clearance when compared
to astrocytes treated without lead (Figure 4). Furthermore,
all of the lead + 3AT treatments yielded significantly slower
rates of H2O2 detoxification than treatment with 3AT alone,
but faster rates than those observed after treatment with BSO
+ 3AT (Figure 4). The D-values of astrocytes treated with
different lead concentrations did not differ significantly from
each other (Figure 4, columns 2–5). Therefore, increasing lead
concentrations do not cause greater impairment of peroxide
clearance. Under the conditions investigated, the lowest lead
concentration applied (10 µM) caused maximal effects on
peroxide clearance in both the presence and the absence
of 3AT.
Toxicity of Treatments with H2O2
Prior to treatment with a bolus of H2O2, the amount of
LDH released by cultures exposed to lead and/or to 3AT
was within the normative range for all treatments (less
than 10% LDH release), indicating that the treatments did
not cause significant cell death (Figure 5A). However, after
60 min incubation with 100 µM H2O2, LDH levels were
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FIGURE 3 | Clearance of H2O2 by rat astrocyte cultures. Cells were
incubated for 60 min with 500 µl of 100 µM H2O2, and media were collected
at the specified time points for measurement of H2O2 concentration.
(A) Dulbecco’s modified eagle medium (DMEM) only control, 1 mM Buthionine
sulfoximine (BSO), 10 mM 3AT or 1 mM BSO + 10 mM 3AT. (B) 10–330 µM
lead acetate. (C) 10–330 µM lead acetate + 10 mM 3AT. Each data point
represents mean ± SD of n = 9 samples.
elevated in all conditions (Figure 5B). When these levels were
analyzed, a one-way ANOVA indicated a significant effect of
treatment (F(11,90) = 12.052, p < 0.05). Dunnett’s T3 post
hoc analyses demonstrated that none of the lead treatments
significantly increased the extent of cell death compared
to the respective control condition (p > 0.05). However,
after 60 min incubation with H2O2, the BSO-treated group
demonstrated a significant increase in LDH release, both in
the presence of 3AT (T3 = 7.483 + 1.073, p < 0.05) and
FIGURE 4 | D-values for H2O2 clearance in rat astrocyte cultures.
Standardized H2O2 clearance values were derived from H2O2 half-times.
The higher the D-values, the faster the rate of detoxification. Incubation
conditions were the same as in Figure 3. Treatment concentrations: 1 mM
BSO, 10 mM 3AT; concentrations for lead (Pb) are in µM. Statistical analyses
were performed on lead-treated conditions. Significant differences (p < 0.05)
between lead-treated and untreated control are represented by ∗. Significant
differences (p < 0.05) between lead + 3AT-treated and 3AT-treated controls
are represented by #. Each bar represents a mean ± SD of n = 9 samples,
except for those treated with 10 µM lead where n = 6.
in the absence of 3AT (T3 = 6.207 + 0.930, p < 0.05;
Figure 5B).
DISCUSSION
While lead intoxication is known to impair GS activity,
uncertainty exists regarding the basis of this impairment. It
is possible that lead binds to the active site of GS inhibiting
it directly, or the inhibition of lead may be a downstream
event, secondary to inactivation of the glutathione system. The
present study conducted experiments to discriminate between
these alternatives. It has been shown that low concentrations
of lead are capable of reducing GS activity in astrocytes that
have been cultured with lead for a week or more (Engle
and Volpe, 1990; Sierra and Tiffany-Castiglioni, 1991). The
present study investigated whether astrocytes incubated with
lead for shorter periods (2 or 24 h) also show an altered
GS activity. Our results revealed that the effect of lead on
specific GS activity in cultured astrocytes is dose- and time-
dependent, with 100 and 330 µM lead acetate significantly
reducing GS activity following 24 h incubation, but not
after 2 h. The slowness of this effect is inconsistent with
a direct inactivation of GS by lead. For instance, direct
inhibitors of GS such as methionine sulfoximine can inhibit
GS activity in intact tissue within minutes (Barnett et al.,
2000).
Previous studies have speculated that lead might bind to
cysteine residues on GS, thereby directly impairing the function
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FIGURE 5 | Cell viability in rat astrocyte cultures before and after 100 µM H2O2 treatment. Incubation conditions were the same as in Figure 3.
(A) Extracellular LDH immediately before application of 100 µM H2O2. (B) Extracellular LDH 60 min after application of 100 µM H2O2. Significant differences
(p < 0.05) between treatments and the untreated controls are represented by # for the no-3AT control group, and by ∗ for the 3AT group. Each bar represents a
mean ± SD of n = 9 samples, except for those treated with 10 µM lead where n = 6.
of this enzyme (Sierra and Tiffany-Castiglioni, 1991; Tang
et al., 1996). This possibility was investigated in the present
study by lysing astrocyte cultures to release their GS and
subsequently incubating the lysates with lead for 35 min.
It was expected that the inhibitory effect of lead would be
rapid and would require lower concentrations than those
effective on living astrocytes, which require time to accumulate
lead. The present results, however, demonstrated that lead
does not inhibit GS activity in cell lysates. Regardless of
the concentration of lead used, GS activity did not differ
from control lysates. These results are inconsistent with an
earlier report (Sierra and Tiffany-Castiglioni, 1991) that direct
application of 10 µM lead is sufficient to maximally inhibit
the activity of GS in astrocyte lysates within 30 min. Those
researchers used a radio ligand assay for GS activity, whereas
we used a colorimetric assay, testing for an enzymatic side
reaction of GS which appears to be unaffected by lead.
Regardless of the reason for this discrepancy, the present
results imply that the inhibition of GS is not caused by lead
binding to cysteine residues at the active site of the enzyme,
and instead may be an indirect consequence of a secondary
mechanism.
While studies have noted that lead toxicity is accompanied
by oxidative stress, there is uncertainty regarding how lead
promotes this, since lead itself is not redox-active. Much of
the evidence points to the fact that lead has an affinity for
sulfhydryl groups and hence may bind readily to GSH and
enzymes in the GSH system (Patrick, 2006; Rubino, 2015),
thereby reducing the cellular capacity to clear H2O2 (Tang et al.,
1996). For example, the blood and tissues (including brain)
of mice exposed to toxic concentrations of lead demonstrate
significantly lower levels of endogenous GSH (Penugonda and
Ercal, 2011). The results of the present study indicate that
when compared to lead-free controls, lead acetate decreased
H2O2 clearance rates, and that the extent of slowing was
about half that caused by the GSH synthesis inhibitor BSO,
regardless of the presence or absence of 3AT in the system.
These observations are consistent with the hypothesis that
lead targets the GSH system by affecting the synthesis and
regeneration of GSH. By slowing the rate of detoxification,
metabolically-produced H2O2 will remain in cells for a longer
period, giving it an increased potential to cause oxidative stress
and to oxidize GS. It should be noted however, that GS activity
in astrocytes is unaffected by the presence of H2O2 alone;
inactivation of GS requires the presence of iron (Fernandes et al.,
2011).
Compounds that block GS activity cause profound memory
impairments and cognitive deficits (e.g., Gibbs et al., 1996;
reviewed by Robinson, 2000). The glutamate-glutamine cycle
can be interrupted by inhibiting astrocytic GS with methionine
sulfoximine (Pow and Robinson, 1994). The subsequent
depletion of glutamate stores and interruption of glutamatergic
neurotransmission occurs with surprising rapidity. For instance,
40 mM doses of methionine sulfoximine delivered to the
retina of rats results in blindness within 2 min, which can
be reversed by the administration of glutamine (Barnett et al.,
2000). Similarly, delivery of methionine sulfoximine into the
hyperstriatum of chicks prevents memory consolidation, an
effect that is reversed by the administration of glutamine,
demonstrating the essential contribution of astrocytic GS to
learning and the consolidation of memories (Gibbs et al., 1996;
Hertz et al., 1996; Gibbs and Hertz, 2005). In rats the inhibition
of GS impairs the temporal component of memories (Kant et al.,
2014).
Verbal and nonverbal memory is impaired in individuals
who have been chronically exposed to lead, with the greatest
deficits being evident in children, particularly with respect to
their global intelligence and capacity to learn (Mason et al.,
2014). The effects of lead intoxication on memory have been
amply demonstrated in animal models (Kuhlmann et al., 1997;
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Barkur et al., 2011). While neurones are sensitive to the toxicity
of lead, they preferentially accumulate it in lysosomes, whereas
astrocytes accumulate lead at a higher rate than neurones and
concentrate it in the nucleus and throughout the cytoplasm
(Holtzman et al., 1987). The results of the present study
support the conclusion that the impairment of learning and
memory in lead intoxication is due to the inactivation of
astrocytic GS. Since the inactivation of GS by lead appears
to be a secondary consequence of inhibition of the GSH
system, it might be possible to reduce the effects of lead on
cognition by providing supplements that boost the activity of
the GSH system. Indeed, (Penugonda and Ercal, 2011) have
shown that when lead-intoxicated rats are provided with N-
acetylcysteine, a precursor of GSH, the depletion of GSH in
the brain and other tissues is reversed. However, it remains to
be shown whether such supplements can lessen the deficits in
learning and memory caused by lead intoxication in rats and
humans.
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